ES2531093T3 - Procedimiento de preparación de halogenuros de N-alquil-naltrexona - Google Patents
Procedimiento de preparación de halogenuros de N-alquil-naltrexona Download PDFInfo
- Publication number
- ES2531093T3 ES2531093T3 ES07848250T ES07848250T ES2531093T3 ES 2531093 T3 ES2531093 T3 ES 2531093T3 ES 07848250 T ES07848250 T ES 07848250T ES 07848250 T ES07848250 T ES 07848250T ES 2531093 T3 ES2531093 T3 ES 2531093T3
- Authority
- ES
- Spain
- Prior art keywords
- naltrexone
- halides
- alkyl
- preparation procedure
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Ion doble de N-metil-naltrexona, de la fórmula:**Fórmula** en forma de anhidro o de hidrato.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0608286A FR2906252B1 (fr) | 2006-09-21 | 2006-09-21 | Procede de preparation d'halogenures de n-aklyl naltrexone |
PCT/FR2007/001516 WO2008034973A1 (fr) | 2006-09-21 | 2007-09-19 | Procede de preparation d'halogenures de n-alkyl naltrexone |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2531093T3 true ES2531093T3 (es) | 2015-03-10 |
Family
ID=38016779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES07848250T Active ES2531093T3 (es) | 2006-09-21 | 2007-09-19 | Procedimiento de preparación de halogenuros de N-alquil-naltrexona |
Country Status (36)
Country | Link |
---|---|
US (2) | US7645880B2 (es) |
EP (1) | EP2069362B1 (es) |
JP (1) | JP5214615B2 (es) |
KR (1) | KR101434693B1 (es) |
CN (2) | CN101516892B (es) |
AR (1) | AR062918A1 (es) |
AU (1) | AU2007298855B2 (es) |
BR (1) | BRPI0718440A2 (es) |
CA (1) | CA2663509C (es) |
CL (1) | CL2007002711A1 (es) |
CO (1) | CO6170362A2 (es) |
CR (1) | CR10660A (es) |
DO (1) | DOP2011000307A (es) |
EA (1) | EA015426B1 (es) |
ES (1) | ES2531093T3 (es) |
FR (1) | FR2906252B1 (es) |
GT (1) | GT200900060A (es) |
HK (1) | HK1135389A1 (es) |
HN (1) | HN2009000503A (es) |
IL (1) | IL197402A (es) |
JO (1) | JO3023B1 (es) |
MA (1) | MA30793B1 (es) |
ME (1) | ME00613B (es) |
MX (1) | MX2009003084A (es) |
MY (1) | MY148094A (es) |
NI (1) | NI200900035A (es) |
NO (1) | NO20091561L (es) |
NZ (1) | NZ575417A (es) |
PE (1) | PE20080867A1 (es) |
SV (1) | SV2009003192A (es) |
TN (1) | TN2009000080A1 (es) |
TW (1) | TWI465451B (es) |
UA (1) | UA96957C2 (es) |
UY (1) | UY30599A1 (es) |
WO (1) | WO2008034973A1 (es) |
ZA (1) | ZA200901846B (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2682129A1 (en) | 2007-03-29 | 2008-10-09 | Progenics Pharmaceuticals, Inc. | Crystal forms and uses thereof |
WO2008138383A1 (de) | 2007-05-16 | 2008-11-20 | Cilag Ag | Verfahren zur herstellung von n-methylnaltrexonbromid |
WO2009009292A2 (en) * | 2007-07-11 | 2009-01-15 | Mallinckrodt Inc. | Crystalline forms of naltrexone methobromide |
EP2019105A1 (en) * | 2007-07-19 | 2009-01-28 | Siegfried Ltd. | Process for the preparation of quaternary n-alkyl morphine or morphinane alkaloid derivatives |
AU2009300379B2 (en) * | 2008-09-30 | 2015-04-02 | SpecGx LLC | Processes for the alkylation of secondary amine groups of morphinan derivatives |
US8563727B2 (en) * | 2009-02-23 | 2013-10-22 | Mallinckrodt Llc | (+)-morphinanium N-oxides and processes for their production |
US8946419B2 (en) | 2009-02-23 | 2015-02-03 | Mallinckrodt Llc | (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives |
US8436174B2 (en) * | 2009-02-23 | 2013-05-07 | Mallinckrodt Llc | (+)-morphinanium quaternary salts and processes for their production |
US8563724B2 (en) * | 2009-02-23 | 2013-10-22 | Mallinckrodt Llc | (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives |
NZ595591A (en) | 2009-04-24 | 2013-11-29 | Univ Brock | Processes for the preparation of morphinane and morphinone compounds |
WO2011009020A2 (en) | 2009-07-16 | 2011-01-20 | Mallinckrodt Inc. | Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers |
CN101845047B (zh) * | 2009-12-31 | 2011-12-07 | 南京臣功制药有限公司 | 一种溴甲基纳曲酮的制备方法 |
AU2011325563B2 (en) | 2010-11-05 | 2015-08-20 | H. Lundbeck A/S | Method for the manufacturing of naltrexone |
US8580963B2 (en) | 2010-11-05 | 2013-11-12 | H. Lundbeck A/S | Method for the manufacturing of naltrexone |
JO3209B1 (ar) * | 2010-11-05 | 2018-03-08 | H Lundbeck As | طريقة لتصنيع نالتريكسون |
WO2012138888A1 (en) | 2011-04-05 | 2012-10-11 | Alkermes, Inc. | Process for the synthesis of quaternary amine compounds |
BR112014005421A2 (pt) | 2011-09-08 | 2017-04-04 | Mallinckrodt Llc | produção de alcaloides sem o isolamento de intermediários |
CN103172640A (zh) * | 2011-12-22 | 2013-06-26 | 天津康鸿医药科技发展有限公司 | 一种(r)-n-溴甲基纳曲酮的制备方法以及纳曲酮衍生物 |
US20140155608A1 (en) | 2012-05-03 | 2014-06-05 | H. Lundbeck A/S | Method for the manufacturing of naltrexone |
CN105985348B (zh) * | 2015-02-12 | 2019-02-01 | 正大天晴药业集团股份有限公司 | 一种溴甲基纳曲酮的制备方法 |
CN106317064B (zh) * | 2015-06-30 | 2018-06-19 | 北大方正集团有限公司 | 溴甲纳曲酮的制备方法 |
KR102201609B1 (ko) * | 2019-04-19 | 2021-01-12 | 연성정밀화학(주) | 날데메딘의 제조방법 |
CN111777617A (zh) * | 2020-07-10 | 2020-10-16 | 华润三九医药股份有限公司 | 一种溴甲纳曲酮的精制方法 |
WO2022076470A1 (en) | 2020-10-06 | 2022-04-14 | Sorrento Therapeutics, Inc. | Oral delayed burst formulation of low-dose naltrexone or naloxone used for|treating fibromyalgia and long covid |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4176186A (en) * | 1978-07-28 | 1979-11-27 | Boehringer Ingelheim Gmbh | Quaternary derivatives of noroxymorphone which relieve intestinal immobility |
US7285665B2 (en) * | 2002-11-08 | 2007-10-23 | Mallinckrodt Inc. | Process for the preparation of quaternary N-alkyl morphinan alkaloid salts |
AR057325A1 (es) * | 2005-05-25 | 2007-11-28 | Progenics Pharm Inc | Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos |
-
2006
- 2006-09-21 FR FR0608286A patent/FR2906252B1/fr not_active Expired - Fee Related
-
2007
- 2007-09-19 BR BRPI0718440-9A2A patent/BRPI0718440A2/pt not_active IP Right Cessation
- 2007-09-19 CN CN2007800350747A patent/CN101516892B/zh not_active Expired - Fee Related
- 2007-09-19 EA EA200970307A patent/EA015426B1/ru not_active IP Right Cessation
- 2007-09-19 CA CA2663509A patent/CA2663509C/fr not_active Expired - Fee Related
- 2007-09-19 MX MX2009003084A patent/MX2009003084A/es active IP Right Grant
- 2007-09-19 UA UAA200903924A patent/UA96957C2/ru unknown
- 2007-09-19 ES ES07848250T patent/ES2531093T3/es active Active
- 2007-09-19 WO PCT/FR2007/001516 patent/WO2008034973A1/fr active Application Filing
- 2007-09-19 CN CN2011101080743A patent/CN102225939A/zh active Pending
- 2007-09-19 JP JP2009528751A patent/JP5214615B2/ja not_active Expired - Fee Related
- 2007-09-19 TW TW096134967A patent/TWI465451B/zh not_active IP Right Cessation
- 2007-09-19 ME MEP-2009-105A patent/ME00613B/me unknown
- 2007-09-19 ZA ZA200901846A patent/ZA200901846B/xx unknown
- 2007-09-19 AU AU2007298855A patent/AU2007298855B2/en not_active Ceased
- 2007-09-19 KR KR1020097005731A patent/KR101434693B1/ko not_active IP Right Cessation
- 2007-09-19 NZ NZ575417A patent/NZ575417A/en not_active IP Right Cessation
- 2007-09-19 EP EP07848250.2A patent/EP2069362B1/fr active Active
- 2007-09-19 MY MYPI20091158A patent/MY148094A/en unknown
- 2007-09-20 JO JOP/2007/0399A patent/JO3023B1/ar active
- 2007-09-20 AR ARP070104157A patent/AR062918A1/es unknown
- 2007-09-20 UY UY30599A patent/UY30599A1/es not_active Application Discontinuation
- 2007-09-20 CL CL200702711A patent/CL2007002711A1/es unknown
- 2007-09-20 PE PE2007001269A patent/PE20080867A1/es not_active Application Discontinuation
-
2008
- 2008-03-17 US US12/049,607 patent/US7645880B2/en not_active Expired - Fee Related
-
2009
- 2009-03-04 IL IL197402A patent/IL197402A/en not_active IP Right Cessation
- 2009-03-10 TN TN2009000080A patent/TN2009000080A1/fr unknown
- 2009-03-11 CR CR10660A patent/CR10660A/es unknown
- 2009-03-12 GT GT200900060A patent/GT200900060A/es unknown
- 2009-03-18 HN HN2009000503A patent/HN2009000503A/es unknown
- 2009-03-19 NI NI200900035A patent/NI200900035A/es unknown
- 2009-03-19 CO CO09028774A patent/CO6170362A2/es active IP Right Grant
- 2009-03-19 SV SV2009003192A patent/SV2009003192A/es active IP Right Grant
- 2009-04-16 MA MA31789A patent/MA30793B1/fr unknown
- 2009-04-20 NO NO20091561A patent/NO20091561L/no not_active Application Discontinuation
- 2009-11-25 US US12/625,649 patent/US8288547B2/en not_active Expired - Fee Related
-
2010
- 2010-02-22 HK HK10101845.3A patent/HK1135389A1/xx not_active IP Right Cessation
-
2011
- 2011-10-07 DO DO2011000307A patent/DOP2011000307A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2531093T3 (es) | Procedimiento de preparación de halogenuros de N-alquil-naltrexona | |
CY1122330T1 (el) | Συνθεσεις δισκιων μηλεϊνικης νερατινιμπης | |
EA201170252A1 (ru) | Амидофеноксиндазолы в качестве ингибиторов c-мет | |
UA107791C2 (en) | Pesticidal compositions | |
EA201070786A1 (ru) | Бензофуропиримидиноны | |
EA201071032A1 (ru) | Гетероциклическое соединение | |
BRPI0907563A2 (pt) | Derivados de 4,5-di-hidro-xazol-2-il amina | |
MA33803B1 (fr) | Inhibiteur de bromodomaine de benzodiazépine | |
WO2010014836A3 (en) | Tgr5 modulators and methods of use thereof | |
TN2011000293A1 (en) | Protein kinase inhibitors | |
HK1155452A1 (en) | 2,6-diamino- pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors syk jak 26---5-yl- | |
EA200970737A1 (ru) | Оксабициклогептаны и оксабициклогептены, их получение и применение | |
RS53745B1 (en) | 6-AMINO-2 - {[(1S) -1-METYLBUTIL] OKSI} -9- [5- (1-PIPERIDINIL) PENTIL] -7,9-DIHIDRO-8H-PURIN-8-ON-MALEAT | |
EA200971068A1 (ru) | Триазолиламинопиримидиновые соединения | |
RS52255B (en) | NALMEFEN HYDROCHLORIDE DIHYDRATE | |
UY29857A1 (es) | Derivados de la 4-amino-quinazolina, su preparación y su aplicación en terapéutica. | |
TNSN08191A1 (en) | Kinase inhibitors | |
TW200700064A (en) | Novel compounds | |
BRPI0922280A2 (pt) | "métodos para preparo de aerogéis híbridos". | |
CO6241120A2 (es) | (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS. | |
EA201290642A1 (ru) | Соединения и способы | |
BRPI0720050A2 (pt) | 6-oxo-1,6-diidropirimidin-2-ilas no tratamento de doenças proliferativas | |
IL251655B (en) | 6,2-diamino-pyrimidin-5-yl-carboxamides as inhibitors of syk or jak kinases | |
UA104420C2 (uk) | Застосування похідних глутарової кислоти або їх фармацевтично прийнятних солей як протиаритмічних засобів | |
MX2010010876A (es) | Piperidinas sustituidas como compuestos terapeuticos. |